GASTROESOPHAGEAL CANCER
Clinical trials for GASTROESOPHAGEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL CANCER trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First patients sought for groundbreaking cancer drug trial
Disease control Not yet recruitingThis is the first study in people to test a new drug called DA 3501 for advanced stomach and pancreatic cancers. The main goals are to find a safe and effective dose and to see how the body handles the drug. About 51 patients with specific types of these cancers will receive the …
Matched conditions: GASTROESOPHAGEAL CANCER
Phase: PHASE1 • Sponsor: Dong-A ST Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New hope for stomach cancer: experimental combo aims to wipe out tumors before surgery
Disease control Not yet recruitingThis study is testing whether adding two new drugs (zanidatamab and tislelizumab) to standard chemotherapy before surgery is safe and more effective for people with HER2-positive stomach or esophageal cancer. The goal is to completely eliminate cancer cells in the tissue removed …
Matched conditions: GASTROESOPHAGEAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC